Details for New Drug Application (NDA): 204882
✉ Email this page to a colleague
The generic ingredient in SILDENAFIL CITRATE is sildenafil citrate. There are twenty drug master file entries for this compound. Sixty-eight suppliers are listed for this compound. Additional details are available on the sildenafil citrate profile page.
Summary for 204882
Tradename: | SILDENAFIL CITRATE |
Applicant: | Rubicon |
Ingredient: | sildenafil citrate |
Patents: | 0 |
Pharmacology for NDA: 204882
Mechanism of Action | Phosphodiesterase 5 Inhibitors |
Medical Subject Heading (MeSH) Categories for 204882
Suppliers and Packaging for NDA: 204882
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 204882 | ANDA | A-S Medication Solutions | 50090-6804 | 50090-6804-0 | 10 TABLET, FILM COATED in 1 BOTTLE (50090-6804-0) |
SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 204882 | ANDA | TruPharma LLC | 52817-340 | 52817-340-30 | 30 TABLET, FILM COATED in 1 BOTTLE (52817-340-30) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 25MG BASE | ||||
Approval Date: | Jun 11, 2018 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 50MG BASE | ||||
Approval Date: | Jun 11, 2018 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 100MG BASE | ||||
Approval Date: | Jun 11, 2018 | TE: | AB | RLD: | No |
Complete Access Available with Subscription